CRISPR/Cas9‐mediated genome editing reveals seven testis‐enriched transmembrane glycoproteins dispensable for male fertility in mice
Andrology · 2025
DOI: 10.1111/andr.13564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Andrology, 2025. Verfasst von Yo Ogawa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Japan. Hauptthemen laut MEDLINE: Testis, Fertility, CRISPR-Cas Systems, Gene Editing. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Japan Society for the Promotion of Science, Japan Science and Technology Agency.
Abstract (Originalsprache)
Background
Mammalian fertilization is mediated by multiple sperm acrosomal proteins, many of which are testis‐enriched transmembrane glycoproteins expressed during spermiogenesis (e.g., Izumo sperm‐egg fusion 1, Sperm acrosome associated 6, and Transmembrane protein 95).
Methods
We hypothesized that proteins with these features might have a role in sperm–egg interaction and thus carried out an in‐silico screen based on multiple public databases. We generated knockout mouse lines lacking seven candidate proteins by the CRISPR/Cas9 system and conducted detailed analyses on the fecundity of the knockout males, as well as their testis appearance and weight, testis and epididymis histology, and sperm motility and morphology.
Results
Through the in‐silico screen, we identified 4932438H23Rik, A disintegrin and metalloproteinase domain‐containing protein 29, SAYSvFN domain‐containing protein 1, Sel‐1 suppressor of lin‐12‐like 2 ( C. elegans ), Testis‐expressed protein 2, Transmembrane and immunoglobulin domain‐containing 3, and Zinc and ring finger 4. Phenotypic analyses unveiled that the knockout males showed normal testis gross appearance, normal testis and epididymis histology, and normal sperm morphology and motility. Fertility tests further indicated that the knockout male mice could sire pups with normal litter sizes when paired with wild‐type females. Discussion and conclusion These findings suggest that these seven proteins are individually dispensable for male reproduction and fertilization. Future studies are warranted to devise advanced in‐silico screening approaches that permit effective identification of gamete fusion‐required sperm proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Japan.
- Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
- Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe), Osaka University, Suita, Japan.
- Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.
- Graduate School of Medicine, Osaka University, Suita, Japan.
- The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Yonggang Lu, Daiji Kiyozumi, Masahito Ikawa
Förderung
- NICHD NIH HHS
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Gates Foundation
- Bill and Melinda Gates Foundation
Zitieren
APA
Ogawa, Y., Lu, Y., Kiyozumi, D., Chang, H. Y., & Ikawa, M. (2025). CRISPR/Cas9‐mediated genome editing reveals seven testis‐enriched transmembrane glycoproteins dispensable for male fertility in mice. Andrology. https://doi.org/10.1111/andr.13564
Vancouver
Ogawa Y, Lu Y, Kiyozumi D, Chang HY, Ikawa M. CRISPR/Cas9‐mediated genome editing reveals seven testis‐enriched transmembrane glycoproteins dispensable for male fertility in mice. Andrology. 2025. doi:10.1111/andr.13564
BibTeX
@article{Ogawa2025,
author = {Ogawa, Yo and Lu, Yonggang and Kiyozumi, Daiji and Chang, Hsin-Yi and Ikawa, Masahito},
title = {CRISPR/Cas9‐mediated genome editing reveals seven testis‐enriched transmembrane glycoproteins dispensable for male fertility in mice},
journal = {Andrology},
year = {2025},
doi = {10.1111/andr.13564}
}
EUVIMED